IP Verse

Direct Compression Formulation And Process

Patent No. EP3366283 (titled "Direct Compression Formulation And Process") was filed by Novartis on Jan 17, 2005. The application was issued on Sep 1, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HOFFMANN EITLEJun 1, 2022-
HAMM & WITTKOPPMay 30, 2022-
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBBMay 30, 2022SONNENHAUSER
INSTONE TERRY READ HOWARD GRAHAMAPPLEYARD LEESMay 23, 2022APPLEYARD LEES
D YOUNGMay 19, 2022-
COOKESep 28, 2021ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3366283

NOVARTIS
Application Number
EP18165545A
Filing Date
Jan 17, 2005
Status
Granted And Under Opposition
Jul 30, 2021
Publication Date
Sep 1, 2021
External Links
Slate, Register , Google Patents